Error message

Access Denied.

Kindly login to proceed or if you are not already registered, register here.

×

For more information, refer to the ADAKVEO® (crizanlizumab) prescribing information available here: www.health.novartis.co.uk/sites/health.novartis.co.uk/files/adakveo-pi.pdf

Legal Category: POM.

Marketing Authorisation (MA) number, quantities and price: EU/1/20/1476/001  £1,038.00 per 10ml vial

 

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via uk.patientsafety@novartis.com or online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at medinfo.uk@novartis.com